Nuvilex Enters Discussions to Acquire Next Generation Technology to Treat Multiple Types of Cancer

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Nuvilex, Inc. (OTCQB: NVLX) announced today it has entered into discussions to acquire the next generation live cell encapsulation technology that serves as the platform for multiple cancer therapies.